AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 587 businesses audited.
NEXPLANON has 31.8 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: NEXPLANON (nexplanon.com)
This is a benchmark for low-BS medical communication, where regulatory oversight has essentially forced the removal of marketing air. The site relies on hyper-granular metrics—like insertion time measured to the tenth of a second—to prove its claims, effectively neutralizing any generic pharmaceutical cliches. It is a high-substance, high-specificity asset that treats the user as a patient rather than a sales target.
1. Add outbound links to the specific clinical trial results on ClinicalTrials.gov to fulfill the ‘proof path’ requirement. 2. Integrate ‘Last Updated’ or ‘Medical Review’ timestamps on data-heavy sections like the ‘Effectiveness’ page to improve temporal authority. 3. Include Organon corporate branding or links to the manufacturer’s manufacturing standards (GMP) to provide a deeper institutional authority footprint beyond the product brand. 4. Implement Person schema for the medical review board to humanize the authoritative claims.
Information density is exceptionally high for a consumer-facing site, with a specific focus on technical metrics over power words. Substance is proven by specific data points such as the device length ‘1.6 inches (4 cm)’ and the clinical trial mean insertion time of ‘27.9 ± 29.3 seconds.’ Heading fluff is nearly non-existent, with H2 and H4 tags serving as functional signposts for patient education rather than marketing hype. A minor penalty was applied for the high frequency of value proposition repetition regarding the ‘5-year’ duration across all four pages.
AI does not see your layout — it sees your DOM. Get a Clinical Semantic Structure Diagnosis to reveal how your page is segmented, weighted, and interpreted.
There is zero semantic drift detected across the crawled pages. The homepage establishes a clear promise of a long-acting, reversible, 99% effective implant, and the sub-pages provide granular evidence for each component of that claim. The transition from the homepage to the ‘How NEXPLANON Works’ and ‘Effectiveness’ pages maintains strict alignment in both technical mechanism descriptions and statistical efficacy claims.
Identify the current state and friction diagnosis of your specific business model. Generate your Executive SEO Strategy to quantify the financial or conversion cost of strategic misalignment.
The site avoids standard trust theatre traps like unverified star ratings or anonymous testimonials, maintaining a professional clinical tone. However, while it references ‘clinical studies’ and ‘clinical trials’ throughout the text (e.g., the 5.2% pain metric), there are 0 proof_links_count in the metadata, meaning no direct outbound links to peer-reviewed PDFs or ClinicalTrials.gov registrations were found in this data. This lack of a direct ‘proof path’ to the source documentation accounts for the points in this pillar.
Proof density is significantly higher than industry averages, with a ratio of approximately one specific data point (milligram dosage, centimeter length, second-based insertion time) for every three sentences of descriptive text. Unlike typical ‘fluff’ sites, this site prioritizes contraindications and side effects (1 in 10 women stopping due to bleeding patterns) alongside efficacy data. The only missing element is the external verification link to the primary study data.
To evaluate URL identity stability and multilingual coherence, review the Yoast Identity Stability audit. View the Yoast Identity Stability Audit for a practical example of canonical alignment and language layer integrity.
The site follows a rigid pharmaceutical template, including required sections for ‘Important Safety Information’ and ‘Indication’ which are industry-standard. The value proposition is highly unique to the specific physical mechanism of an arm-based implant, preventing the copy-paste vulnerability common in commodity markets. Cliché usage is restricted to mandatory regulatory phrases like ‘FDA approved’ (implied) and ‘prescription birth control,’ which serve as legal substance rather than marketing fluff.
Authority is established through technical accuracy and regulatory compliance rather than individual expert personalities. The schema_json correctly identifies the site as a MedicalWebPage for a MedicalAudience, though it lacks Person schema or direct bios for lead medical advisors or the pharmaceutical parent company, Organon. The technical implementation is clean, with a clear heading hierarchy that supports the authoritative medical positioning.
The site demonstrates a rare 1:1 alignment between marketing claims and technical demonstration. Claims of ‘99% effectiveness’ are immediately quantified as ‘less than 1 pregnancy per 100 women who used NEXPLANON for 1 year.’ The performance claim regarding ease of use is backed by the ‘outpatient office visit’ details and the 27.9-second insertion statistic, leaving no gap between the marketing signal and clinical reality.
Medical Devices, Pharma & Biotech BS: NEXPLANON (nexplanon.com)
The site perfectly matches the Medical Devices and Pharma category, characterized by heavy regulatory language, specific clinical data, and defined indications for use. The presence of ‘Important Safety Information’ and ‘Indication’ blocks confirms a highly compliant pharmaceutical digital footprint.
When your canonical, redirect, and final URL disagree, the model treats each version as a separate entity. Study the Canonical Integrity Framework Guide and see why stable identity is the prerequisite for AI driven retrieval.
“The score of 9 is one of the lowest possible, driven primarily by the site's refusal to use unquantified power words and its reliance on forensic medical data. Small point deductions occurred in Trust and Proof due to the absence of direct outbound proof links in the metadata, and in Information Density for the repetitive (though likely legally required) restatement of the 5-year duration claim. Overall, the site represents maximum substance.”